Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 68.00
-1.00 (-1.45%)
Sep 16, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 5.33 billion as of September 15, 2026. Its market cap has decreased by -47.43% in one year.
Market Cap
5.33B
Enterprise Value
2.82B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
68.00
ChartMarket Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 5.33B, a decrease of -57.64%. That is a compound annual growth rate of -31.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 5.33B | -28.45% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 6.78B |
| Cyfuse Biomedical K.K. | 6.68B |
| CellSource | 6.47B |
| Noile-Immune Biotech | 6.03B |
| PRISM BioLab Co.,LTD | 5.95B |
| TMS Co., Ltd. | 5.71B |
| Soiken Holdings | 5.57B |
| D. Western Therapeutics Institute | 5.01B |